Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RLC Laboratories is a specialty pharmaceutical company that focused on the treatment of hypothyroidism and endocrine disorders. The company gained prominence for its natural desiccated thyroid (NDT) medications, specifically Nature-Throid and WP Thyroid, which are derived from porcine thyroid glands. In addition to its prescription drug line, RLC offered a suite of dietary supplements designed to support adrenal and thyroid function, such as a-Drenal and i-Throid. Following a series of comprehensive product recalls in 2020 due to potency issues and subsequent regulatory scrutiny from the FDA, the company's manufacturing operations for its core thyroid products have been largely suspended. Consequently, its primary medications are currently unavailable in the United States market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RLC Laboratories.